Abstract
While some users show increased sexual functioning due to substance use, the chronic use of legal and illicit drugs increases the rates of sexual dysfunctions. Especially in connection with substance use, it remains difficult to disentangle cultural, social, psychological, and biological etiological factors in sexual dysfunctions. This chapter, however, reviews the existing empirical data on substance-related disorders and sexual dysfunctions and intervention programs. Moreover, it will discuss if there are any substances with potentially enhancing effects on sexual functioning. The first part of the chapter consists of a general introduction and classification of substance-related disorders and sexual dysfunctions in DSM-5 and ICD-11. The second part presents empirical findings on various substances and sexual functioning in greater details. The last part presents possibilities of prevention and intervention of sexual dysfunctions in association with substance and two case reports. Furthermore, the reader will find take-home messages at the end of this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Palha AP, Esteves M. Drugs of abuse and sexual functioning. Sex Dysfunct. 2008;29:131–49. September 2014.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Association; 2013.
World health organization. Classification of diseases (ICD). https://www.who.int/classifications/icd/revision/en/.
Bancroft J, Graham CA, Janssen E, et al. The dual control model: current status and future directions. J Sex Res. 2009;46(2–3):121–42.
Nolet K, Larouche Wilson A, Rouleau JL. Using the dual control model to understand problematic sexual behaviors in men. Theol Sex. 2017;26(4):e55–8.
Clayton AH. Epidemiology and neurobiology of female sexual dysfunction. J Sex Med. 2007;4(4):260–8.
Shakespeare W. The tragedy of macbeth. n.d.. https://www.bartleby.com/46/4/23.html. Accessed 11 Dec 2018.
Grover S, Matto SK, Pendharker S, et al. Sexual dysfunction in patients with alcohol and opioid dependence. Indian J Psychol Med. 2014;36(4):355–65.
Peugh J, Belenko S. Alcohol, drugs and sexual function: a review alcohol, drugs and sexual function: a review. J Psychoactive Drugs. 2001;33(3):223–32.
Nordmann R, Ribière C, Rouach H. Ethanol-induced lipid peroxidation and oxidative stress in extrahepatic tissues. Alcohol Alcohol. 1990;25(2–3):231–7.
Rivier C, Rivest S, Vale W. Alcohol-induced inhibition of LH secretion in intact and gonadectomized male and female rats: possible mechanisms. Alcohol Clin Exp Res. 1992;16(5):935–41.
O’Farrell TJ, Kleinke CL, Cutter HSG. Sexual adjustment of male alcoholics: changes from before to after receiving alcoholism counseling with and without marital therapy. Addict Behav. 1998;23(3):419–25.
Lemere F, Smith JW. Alcohol-induced sexual impotence. Am J Psychiatr. 1973;130(2):212–3.
Klassen AD, Wilsnack SC. Sexual experience and drinking among women in a U. S National survey. Arch Gen Psychiatry. 1986;15(5):363–90.
Malatesta VJ, Pollack RH, Crotty TD, et al. Acute alcohol intoxication and female orgasmic response. J Sex Res. 1982;18(1):1–17.
Wilson GT, Lawson DM. Effects of alcohol on sexual arousal in women. J Abnorm Psychol. 1976;85(5):489–97.
Wilson GT, Lawson DM. Expectancies, alcohol, and sexual arousal in women. J Abnorm Psychol. 1978;87(3):358–67.
Covington SS, Kohen J. Women, alcohol, and sexuality. Adv Alcohol Subst Abuse. 1984;4(1):41–56.
Negus SS, Henriksen SJ, Mattox A, et al. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther. 1993;265(3):1245–52.
Redish AD, Jensen S, Johnson A. A unified framework for addiction: vulnerabilities in the decision process. NIH Public Access. 2013;31(4):415–87.
United Nations. World drug report 2018. United Nations publication, Sales No. E.18.XI.9; 2018.
Mateu-Gelabert P, Guarino H, Jessell L, et al. Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. J Subst Abus Treat. 2015;48(1):13–20.
Miller NS, Gold MS. The human sexual response and alcohol and drugs. J Subst Abus Treat. 1988;5:171–7.
Yee A, Loh HS, Hashim HMBH, et al. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study. Int J Impot Res. 2014;26:161–6.
Shamloul R, Bella AJ. Impact of cannabis use on male sexual health. J Sex Med. 2011;8(4):971–5.
Nocerino E, Amato M, Izzo AA. Cannabis and cannabinoid receptors. Fitoterapia. 2000;71(SUPPL. 1):S6.
Smith AMA, Ferris JA, Simpson JM, et al. Cannabis use and sexual health. J Sex Med. 2010;7:787–93.
Peate I. The effects of smoking on the reproductive health of men. Br J Nurs. 2005;14(7):362–6.
Sipski ML. Spinal cord injury: what is the effect on sexual response? J Am Paraplegia Soc. 1991;14(2):40–3.
Wespes E. Erectile dysfunction: the medical treatment. Eur Urol Suppl. 2013;12(2):13–7.
Sullivan ME, Keoghane SR, Miller MAW. Vascular risk factors and erectile dysfunction. BJU Int. 2001;87(9):838–45.
Talhout R, Schulz T, Florek E. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health. 2011;8(2):613–28.
Ritz MC, Lamb RJ, Goldberg SR, et al. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987;237(4819):1219–23.
Zaazaa A, Bella AJ, Shamloul R. Drug addiction and sexual dysfunction. Endocrinol Metab Clin. 2013;42(3):585–92.
Cocores JA, Miller NS, Pottash AC, et al. Sexual dysfunction in abusers of cocaine and alcohol. Am J Drug Alcohol Abuse. 1988;14(2):169–73.
Raj A, Saitz R, Cheng DM, et al. Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33(1):169–78.
Sulzer D, Sonders MS, Poulsen NW, et al. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005;75:406–33.
Chou N, Huang Y, Jiann B. The impact of illicit use of amphetamine on male sexual functions. J Sex Med. 2015;12:1694–702.
Beck J, Rosenbaum M. Pursuit of ecstasy: the MDMA experience. Albany, NY: State University of New York Press; 1994.
Passie T, Hartmann U, Schneider U, et al. Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion. Med Hypotheses. 2005;64(5):899–903.
Dublin N, Razack AH. Priapism: ecstasy related? Urology. 2000;56(6):1057.
McKay A. Sexuality and substance use: the impact of tobacco, alcohol, and selected recreational drugs on sexual function. Can J Hum Sex. 2005;14(1–2):47–56.
Semple SJ, Grand I, Patterson TL. Female methamphetamine users: social characteristics and sexual risk behavior. Women Health. 2004;40(3):35–50.
Maxwell JC. Emerging research on methamphetamine. Curr Opin Psychiatry. 2005;18(3):235–42.
McCall H, Adams N, Mason D, et al. What is chemsex and why does it matter? BMJ (Online). 2015;351(November):2–3.
Lawn W, Aldridge A, Xia R, et al. Substance-linked sex in heterosexual, homosexual, and bisexual men and women: an online, cross-sectional “global drug survey” report. J Sex Med. 2019;16(5):721–32.
Bourne A, Reid D, Hickson F. Illicit drug use in sexual settings ('chemsex') and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2015;91(8):564–8.
Gessa GL, Agabio R, Carai MAM, et al. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. Alcohol. 2000;20(3):271–6.
Schwartz RH, Milteer R, LeBeau MA. Drug-facilitated sexual assault (‘date rape’). South Med J. 2000;93(6):558–61.
Bosch OG, Havranek MM, Baumberger A, et al. Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans. Eur Neuropsychopharmacol. 2017;27(4):372–82.
Lea T, Reynolds R, De Wit J. Mephedrone use among same-sex attracted young people in Sydney, Australia. Drug Alcohol Rev. 2011;30(4):438–40.
German GL, Fleckenstein AE, Hanson GR. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci. 2014;97(1):2–8.
Dybdal-Hargreaves NF, Holder ND, Ottoson PE, et al. Mephedrone: public health risk, mechanisms of action, and behavioral effects. Eur J Pharmacol. 2013;714(1–3):32–40.
Masters W, Johnson VE. Human sexual response. New York: Little, Brown and Company; 1966.
Masters W, Johnson VE. Human sexual inadequacy. New York: Little, Brown and Company; 1970.
Weiner L, Avery-clark C. Sensate focus: clarifying the Masters and Johnson’s model. Sex Relatsh Ther. 2014;29(3):1–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Engel, J., Krüger, T.H.C. (2021). Substance-Related Disorders. In: Lew-Starowicz, M., Giraldi, A., Krüger, T. (eds) Psychiatry and Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-52298-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-52298-8_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-52297-1
Online ISBN: 978-3-030-52298-8
eBook Packages: MedicineMedicine (R0)